Clinical Experience With Nintedanib For Idiopathic Pulmonary Fibrosis In 3 Uk Tertiary Interstitial Lung Disease Centres

被引:0
|
作者
Toellner, H. [1 ]
Beswick, W. [2 ]
Crooks, M. [2 ]
Donaldson, C. [3 ]
Forrest, I. [3 ]
Hart, S. [2 ]
Leonard, C.
Major, M. [2 ]
Simpson, A. [3 ]
Chaudhuri, N. [4 ]
机构
[1] Univ Manchester, Manchester, Lancs, England
[2] Hull & East Yorkshire Hosp NHS Trust, Kingston Upon Hull, N Humberside, England
[3] Newcastle Upon Tyne Hosp NHS Trust, Newcastle Upon Tyne, Tyne & Wear, England
[4] Univ Hosp South Manchester, Wythenshawe, Scotland
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A5384
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Proportion of idiopathic pulmonary fibrosis among interstitial lung disease in a tertiary care center and its response to treatment
    Puthiyaveettil, Suraj Kozhiparambath
    Edakalavan, Jyothi
    Kumar, Neethu Kesava
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [32] Idiopathic pulmonary fibrosis and systemic sclerosis-interstitial lung disease: features at admission to a tertiary pulmonology unit
    Vettori, Serena
    Lanza, Maurizia
    Annunziata, Anna
    Cauteruccio, Rosa
    Coppola, Antonietta
    Di Spirito, Valentina
    De Simone, Francesco
    Gioia, Sara
    Imitazione, Pasquale
    Stefanelli, Francesco
    Fiorentino, Giuseppe
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [33] Pirfenidone in idiopathic pulmonary fibrosis - Real life experience from a german tertiary referral centre for interstitial lung diseases
    Oltmanns, Ute
    Kahn, Nicolas
    Wenz, Heinrich
    Heussel, Claus-Peter
    Puderbach, Michael
    Ehlers-Tenenbaum, Svenja
    Warth, Arne
    Herth, Felix
    Schnabel, Philip
    Kreuter, Michael
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [34] Nintedanib reduces pulmonary fibrosis in a model of rheumatoid arthritis-associated interstitial lung disease
    Redente, Elizabeth F.
    Aguilar, Martin A.
    Black, Bart P.
    Edelman, Benjamin L.
    Bahadur, Ali N.
    Humphries, Stephen M.
    Lynch, David A.
    Wollin, Lutz
    Riches, David W. H.
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2018, 314 (06) : L998 - L1009
  • [35] Initial clinical experience with nintedanib for treatment of idiopathic pulmonary fibrosis (IPF): About 20 cases
    Valenzuela, Claudia
    Molina, Maria
    Diaz Chantar, Fatima
    Alonso, Tamara
    Rodriguez Portal, Jose Antonio
    Rodriguez Nieto, Maria Jesus
    Laporta, Rosalia
    Jesus Linares, Maria
    Ancochea, Julio
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [36] Nintedanib in the management of idiopathic pulmonary fibrosis: clinical trial evidence and real-world experience
    Rivera-Ortega, Pilar
    Hayton, Conal
    Blaikley, John
    Leonard, Colm
    Chaudhuri, Nazia
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2018, 12
  • [37] Outcome of lung transplantation in non-idiopathic pulmonary fibrosis interstitial lung disease
    Bode, Hannelore
    Verleden, Stijn E.
    Wuyts, Wim A.
    Yserbyt, Jonas
    Verleden, Geert M.
    Vos, Robin
    CLINICAL TRANSPLANTATION, 2019, 33 (10)
  • [38] The Effectiveness of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis, Familial Pulmonary Fibrosis and Progressive Fibrosing Interstitial Lung Diseases: A Real-World Study
    Cameli, Paolo
    Alonzi, Valerio
    d'Alessandro, Miriana
    Bergantini, Laura
    Pordon, Elena
    Guerrieri, Marco
    Refini, Rosa Metella
    Sestini, Piersante
    Bargagli, Elena
    BIOMEDICINES, 2022, 10 (08)
  • [39] Use of nintedanib in interstitial lung disease other than idiopathic pulmonary fibrosis: Much caution is warranted (vol 66, 101987, 2021)
    Mura, Marco
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2020, 65
  • [40] REAL-WORLD TOLERABILITY STUDY OF NINTEDANIB IN PATIENTS WITH PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASE COMPARED TO PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS
    Newman, K.
    Gadoot, T.
    Stranks, L.
    Morris, H.
    Zakis, K.
    Swale, J.
    Greaves, M.
    Stanel, S.
    Ramjug, S.
    Avram, C.
    Blaikley, J.
    Leonard, C.
    Hayton, C.
    Rivera-Ortega, P.
    THORAX, 2022, 77 : A96 - A96